In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

Academic Article

Digital Object Identifier (doi)

Author List

  • Nowak-Gottl U; Dietrich K; Schaffranek D; Eldin NS; Yasui Y; Geisen C; Mitchell LG
  • Start Page

  • 6101
  • End Page

  • 6105
  • Volume

  • 116
  • Issue

  • 26